In addition, the comprehensive evaluation of the risk of bias and the certainty of evidence according to GRADE, and the demonstration that arylesterase activity (not associated with PON-1 polymorphism) was also decreased in asthma patients significantly strengthen the conclusion of our study. The gene discussed is PON1; the disease is asthma.